Natalizumab SC starting and switching

What are the practicalities for initiating and/or switching patients to subcutaneous (SC) natalizumab? Learn the recommendations, and also why injection-site reactions from SC-administered monoclonal antibodies are generally minimal.

Biogen-107547.
Date of preparation: June 2021.